Status:
COMPLETED
Monitoring the HePAtological TOXicity of Drugs (HePATOX)
Lead Sponsor:
Groupe Hospitalier Pitie-Salpetriere
Conditions:
Liver Diseases
Liver Dysfunction
Eligibility:
All Genders
18+ years
Brief Summary
Several drugs and chemotherapies seem to have an impact on the hepatological system. This study investigates reports of hepatological toxicities, including the International classification of disease ...
Detailed Description
Several drugs and chemotherapies seem to have an impact on the hepatological system and are responsible of a wide range of hepatological diseases and side effects. Those are poorly described, due to t...
Eligibility Criteria
Inclusion
- Case reported in the WHO's pharmacovigilance database till 04/02/2019
Exclusion
- Chronology not compatible between the drug and the toxicity
Key Trial Info
Start Date :
February 4 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 4 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03833297
Start Date
February 4 2019
End Date
April 4 2023
Last Update
April 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM
Paris, France, 75013